Selenium: The Thyroid Cofactor

The thyroid holds more selenium per gram than any other organ. That is not a curiosity — it is a clue. Making thyroid hormone is chemically violent work, and the enzymes that both protect the gland from its own chemistry and activate the hormone it produces are all built around selenium. Which is why a thyroid can produce perfectly adequate T4 while the person still runs short of the active hormone that does the work.

What selenium does, and where

Selenium is not used loosely. It is incorporated as selenocysteine into a defined set of roughly twenty-five selenoproteins, each with a specific job. Three families matter here:

• The deiodinases, which convert thyroid hormone between its inactive and active forms
• Glutathione peroxidases, which neutralise hydrogen peroxide and other oxidants
• Thioredoxin reductases, which maintain the cell's redox balance and support DNA synthesis

Two are directly involved in thyroid biology and the third supports the tissue doing the work (Schomburg, Nat Rev Endocrinol 2011). When intake is low the body prioritises rather than sharing the shortfall evenly, and the thyroid holds its selenium longer than most tissues — protective, but it also means a whole-body deficiency can be well established before the gland shows it.

The deiodinases, and why they are the whole story

The thyroid mostly produces T4, which is close to inert. Almost all the biological effect comes from T3, and almost all circulating T3 is made outside the thyroid by removing one iodine atom from T4. The enzymes that do it are selenium-dependent (Köhrle, Int J Mol Sci 2023). There are three, and they do different jobs (Bianco et al., Endocr Rev 2002):

• D1 — liver, kidney, thyroid. Contributes to circulating T3 and clears reverse T3.
• D2 — brain, pituitary, muscle, brown fat. Generates T3 locally, inside the cell that needs it. This is how a tissue sets its own thyroid exposure independently of the blood.
• D3 — the off switch. Converts T4 to reverse T3 and T3 to an inactive form, reducing signalling when the body wants it reduced, as in serious illness.

The consequence: thyroid output and thyroid action are separate things, divided by an enzymatic step that requires a trace mineral. TSH describes the first, not the second.

The other job: cleaning up the mess

Thyroid hormone synthesis requires hydrogen peroxide. The gland generates it deliberately at the follicular surface so iodine can be attached to thyroglobulin — and it is straightforwardly damaging to the cells producing it.

Glutathione peroxidases stand between the two, and they are selenoproteins. In deficiency that defence weakens while peroxide production continues — the most plausible mechanism linking low selenium to thyroid tissue damage and autoimmune thyroid disease, and the reason hormone activation and antioxidant defence are not really separate stories (Winther et al., Nat Rev Endocrinol 2020).

What deficiency looks like on a panel

It rarely announces itself. The pattern that raises the question is a normal TSH and a normal or low-normal free T4 alongside a free T3 lower than it should be — the signature of adequate production and impaired conversion. Reverse T3 may run high, because D3 is unaffected while D1 falters.

Selenium is only one possible cause. Chronic illness, energy restriction, high cortisol and low ferritin suppress conversion through overlapping routes, and reverse T3 covers the stress-driven version. Selenium is worth checking because it is cheap to measure and straightforward to correct. Free T3 versus free T4 explains why a panel that stops at TSH cannot see any of this.

Selenium and thyroid antibodies: the honest version

This is where enthusiasm outruns evidence, so precision matters. Supplementation in autoimmune thyroiditis lowers thyroid peroxidase antibody titres — an old finding, replicated, and not seriously disputed (Gärtner et al., J Clin Endocrinol Metab 2002).

What has not been shown is that the antibody change translates into outcomes patients care about. Systematic review finds the effect on titres but low-certainty or absent evidence for improved thyroid function, less need for thyroid hormone, better quality of life, or slower progression to overt hypothyroidism (Huwiler et al., Thyroid 2024).

An antibody titre marks the process rather than being it. Moving it is encouraging and may well matter; it has not been shown to. Anyone offered selenium as a treatment for Hashimoto's should be told that distinction — thyroid antibodies covers what the titres do and do not tell you.

Testing and ranges

• Optimal serum selenium: 120-180 µg/L. This is roughly the range at which the selenoproteins appear to be saturated — adding more does not add function.
• Below 100 µg/L: deficient, and the range where correction is most likely to change something.
• Above 250 µg/L: more than the body has a use for, and the direction in which the risks begin.

Status depends heavily on where your food was grown, because plant selenium follows soil selenium, which varies enormously by region. Two people eating an identical diet in different countries can sit at opposite ends of that range.

Food first, and the Brazil nut problem

Brazil nuts are the most concentrated common source, and one or two daily is generally enough to move status in a deficient person. The catch is that their content varies by more than an order of magnitude depending on where the tree grew, so "two nuts a day" is a dose with an unknown denominator. Fish, shellfish, eggs and organ meats are more predictable if less dramatic.

The practical rule: use food to maintain adequacy, and use a measured supplement to correct a measured deficiency.

When supplementation makes sense, and the ceiling

Typical supplemental intake is 100-200 µg daily, usually as selenomethionine, which is well absorbed — enough to correct a low level over a few months without approaching the range where problems start.

There is a real ceiling. Sustained intake above roughly 400 µg daily risks selenosis — hair and nail changes, garlic-smelling breath, gastrointestinal upset, and in severe cases neurological effects (Linn et al., J Trace Elem Med Biol 2025). Less dramatically, long-term supplementation in people who were already replete has been associated with a higher incidence of type 2 diabetes in randomised follow-up (Stranges et al., Ann Intern Med 2007).

That is why this is a test-then-treat mineral rather than a default addition to a stack. Selenium has a U-shaped relationship with health: too little is a problem, and more than enough is a different problem. Nothing is gained by going past adequate.

What to expect

Serum selenium responds within weeks. Antibody titres, where they move, do so over three to six months, and free T3 changes appear over a similar period if the deficiency was genuinely limiting conversion. If free T3 has not moved in six months on a corrected level, selenium was not the constraint and the search continues elsewhere. Retest rather than assume, and check iodine status alongside it, since the two interact and correcting one without the other can be counterproductive.

Bottom line

Selenium sits at the centre of thyroid biology twice over: the deiodinases that turn T4 into active T3 are selenoproteins, and so are the glutathione peroxidases protecting the gland from the peroxide it generates to make hormone. Deficiency therefore shows up as impaired conversion — adequate output, insufficient action — rather than as an abnormal TSH. Correcting a genuine deficiency is cheap and sensible; supplementing past adequacy is not, and carries its own risks. It lowers antibody titres, which is interesting but has not been shown to change clinical outcomes. Measure it, correct it if low, then look elsewhere.

Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.